Chemomab Therapeutics Ltd. (CMMB)

Chemomab Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.07	9.29	13.52	15.19	11.67
Short-Term Investments	8.2	10.49	26.37	45.98	0.02
Cash & Short-Term Investments	14.27	19.78	39.89	61.16	11.7
Cash Growth	-27.89%	-50.41%	-34.77%	422.83%	-4.58%
Other Receivables	1.7	0.29	0.46	0.18	0.07
Receivables	1.7	0.29	0.46	0.18	0.07
Prepaid Expenses	-	0.75	1.31	1.35	0.07
Restricted Cash	0.08	0.08	0.08	-	-
Total Current Assets	16.04	20.9	41.74	62.69	11.84
Property, Plant & Equipment	0.54	0.7	0.59	0.7	0.58
Other Long-Term Assets	0.39	0.56	0.73	0.96	0.06
Total Assets	16.96	22.15	43.06	64.35	12.48
Accounts Payable	0.67	0.52	1.69	1.34	0.09
Accrued Expenses	2.44	4.25	4.94	1.21	1.15
Current Portion of Leases	0.12	0.08	0.12	0.11	0.07
Total Current Liabilities	3.22	4.84	6.75	2.65	1.32
Long-Term Leases	0.21	0.32	0.09	0.24	0.36
Total Liabilities	3.43	5.15	6.84	2.89	1.67
Additional Paid-In Capital	116.16	105.68	101.26	97.64	34.5
Retained Earnings	-102.62	-88.68	-63.82	-36.17	-23.7
Treasury Stock	-	-	-1.22	-	-
Total Common Equity	13.54	17	36.22	61.47	10.8
Shareholders' Equity	13.54	17	36.22	61.47	10.8
Total Liabilities & Equity	16.96	22.15	43.06	64.35	12.48
Total Debt	0.32	0.39	0.21	0.34	0.43
Net Cash (Debt)	13.94	19.39	39.68	60.82	11.27
Net Cash Growth	-28.10%	-51.13%	-34.76%	439.64%	-6.58%
Net Cash Per Share	0.86	1.65	3.49	5.86	1.65
Filing Date Shares Outstanding	18.86	14.2	11.05	11.4	-
Total Common Shares Outstanding	18.86	14.2	11.05	11.4	-
Working Capital	12.82	16.06	34.99	60.04	10.52
Book Value Per Share	0.72	1.20	3.28	5.39	-
Tangible Book Value	13.54	17	36.22	61.47	10.8
Tangible Book Value Per Share	0.72	1.20	3.28	5.39	-
Machinery	-	0.5	0.5	0.43	0.21
Leasehold Improvements	-	0.01	0.02	0.02	0.01

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q